online medical consultations for glp-1 obesity treatment Virtual startups: Pill mills or the future of care? GLP-1 Obesity Treatment: What Clinicians

In TRANSCEND-T2D-1 (type 2 diabetes): nausea 26.5%, diarrhea 22.8%, vomiting 17.6%, dysesthesia 4.4%

It is important to note that the prescribing information for each GLP-1 RA medication includes warnings about potential delays in gastric emptying, along with side effects such as delayed gastric emptying, nausea, and vomiting

"I started at 222 pounds in April and now here we are in August and I am down over 40 pounds

Three to six months of jumping through hoops before you can even get the medication

Retatrutide is a GLP-1/GIP/GCG triple agonist, not a steroid

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication